[ad_1]
Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study springermedicine.com
[ad_2]
Related Posts
Measles reported in eastern Idaho unvaccinated child, marking state’s first case in 2026 • Idaho Capital Sun
[ad_1] A child in Madison County contracted measles after traveling out of state to an area with an active outbreak, eastern Idaho health officials said […]
Professors Richard DiMarchi and Rolf Müller recognised with Tu Youyou Award
[ad_1] Award acknowledges exceptional scholars committed to the research fields of natural products chemistry and medicinal chemistry Two researchers were recently recognised for pioneering breakthroughs […]
Carmen Monge-Montero: What NOT to Say to Someone With Cancer and What to Say Instead
[ad_1] Carmen Monge-Montero, Researcher and Global Cancer Advocate, shared a post on LinkedIn: “Heading into holiday season = family gatherings = awkward cancer conversations? I wanted […]